Cargando…

Response to: Kumar N, Ahmed M. Letter to the editor in response to Komen et al. 2021

Detalles Bibliográficos
Autores principales:	Komen, Joris J, Forslund, Tomas, Mantel-Teeuwisse, Aukje K, Klungel, Olaf H, von Euler, Mia, Braunschweig, Frieder, Wallén, Håkan, Hjemdahl, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141297/ https://www.ncbi.nlm.nih.gov/pubmed/33768234 http://dx.doi.org/10.1093/ehjcvp/pvab028

Ejemplares similares

Association of preceding antithrombotic therapy in atrial fibrillation patients with ischaemic stroke, intracranial haemorrhage, or gastrointestinal bleed and mortality
por: Komen, Joris J, et al.
Publicado: (2019)

Long-term persistence and adherence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk
por: Komen, Joris J, et al.
Publicado: (2020)

Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds
por: Komen, Joris, et al.
Publicado: (2022)

Letter to the editor in response to Komen et al. 2021
por: Kumar, Niraj S, et al.
Publicado: (2021)

Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study( )
por: Komen, Joris J, et al.
Publicado: (2022)

Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries
por: Komen, Joris J, et al.
Publicado: (2021)

Factors associated with antithrombotic treatment decisions for stroke prevention in atrial fibrillation in the Stockholm region after the introduction of NOACs
por: Komen, Joris, et al.
Publicado: (2017)

Bedden komen sneller vrij
por: Gibbels, Mario
Publicado: (2020)

'Twee werelden komen samen'
por: Nelissen, Paula
Publicado: (2020)

“Mag ik weer op het spreekuur komen, dokter?”
por: Smeele, Ivo
Publicado: (2020)

Poems by Kumar
por: Kumar, Vinay
Publicado: (2008)

Impact of regulatory requirements on medicine registration in African countries – perceptions and experiences of pharmaceutical companies in South Africa
por: Narsai, Kirti, et al.
Publicado: (2012)

Greedy caliper propensity score matching can yield variable estimates of the treatment‐outcome association—A simulation study
por: Komen, Joris J., et al.
Publicado: (2021)

Pre‐approval and post‐approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs
por: Bloem, Lourens T., et al.
Publicado: (2022)

Dr. N Kumar
por: Elangovan, P.
Publicado: (2010)

Kumar Krishna, in appreciation
por: Engel, Michael S., et al.
Publicado: (2011)

Response from the Authors (Kumar P et al)[1]
Publicado: (2018)

Letter to the editor in response to the article: “Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis (Kumar et al.)”
por: Kumar Singh, Awadhesh, et al.
Publicado: (2020)

Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study
por: Sagwa, Evans L, et al.
Publicado: (2014)

Dr. Shyamal Kumar Sen
por: Chakravarty, Ambar
Publicado: (2011)

Prof. Sudhir Kumar Bhatnagar
por: Bhattacharya, Surajit
Publicado: (2009)

Dr. Arun Kumar Patil
por: Mallanna, BP
Publicado: (2013)

Prof. Shyamal Kumar Roy
por: Datta, Anjan
Publicado: (2012)

REPLY: Reply to Kumar and colleagues
por: Kirklin, James K.
Publicado: (2022)

Regulatory Scientific Advice on Non-Inferiority Drug Trials
por: Wangge, Grace, et al.
Publicado: (2013)

The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs
por: Vreman, Rick A., et al.
Publicado: (2020)

Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies
por: Bloem, Lourens T., et al.
Publicado: (2021)

Obituary: Professor Arun Kumar Gupta
por: Bhan, Surya
Publicado: (2008)

Prof. Rajeev Kumar: adrenal masses
por: Gao, Lucine M.
Publicado: (2016)

A Conversation with Ashok Kumar Singh
por: Chawla, Dalmeet Singh
Publicado: (2022)

Availability, prices and affordability of UN Commission’s lifesaving medicines for reproductive and maternal health in Uganda
por: Kibira, Denis, et al.
Publicado: (2017)

Valproic acid utilization among girls and women in Stockholm: Impact of regulatory restrictions
por: Karlsson Lind, Linnéa, et al.
Publicado: (2018)

Going beyond bibliometrics: A system to track the progress and impact of biomedical research funded by Susan G. Komen
por: Dworkin, Amy M., et al.
Publicado: (2022)

Selection of Essential Medicines for Diabetes in Low and Middle Income Countries: A Survey of 32 National Essential Medicines Lists
por: Bazargani, Yaser T., et al.
Publicado: (2014)

Characteristics of drugs safety signals that predict safety related product information update
por: Insani, Widya N., et al.
Publicado: (2018)

The double opioid crisis: A call for balance
por: Vranken, Marjolein J.M., et al.
Publicado: (2019)

Systematic reviews of ten pharmaceutical pricing policies – a research protocol
por: Tordrup, David, et al.
Publicado: (2020)

Susan G. Komen Big Data for Breast Cancer Initiative: How Patient Advocacy Organizations Can Facilitate Using Big Data to Improve Patient Outcomes
por: Jourquin, Jerome, et al.
Publicado: (2019)

Prof. Shyamal Kumar Das (1954–2018)
por: Ghosh, Bhaskar
Publicado: (2018)

Professor Prem Kumar Chhajed (1945–2019)
por: Govila, Ashok
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j6mkogbf5d806g3ct9o82e91hu